ADC Therapeutics (ADCT) Capital Expenditures (QoQ) (2020 - 2025)
ADC Therapeutics (ADCT) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 193.33% |
| Dec 31, 2024 | -58.33% |
| Sep 30, 2024 | 620.00% |
| Jun 30, 2024 | -94.35% |
| Mar 31, 2024 | 62.39% |
| Dec 31, 2023 | -50.53% |
| Sep 30, 2023 | -45.46% |
| Jun 30, 2023 | 19.29% |
| Mar 31, 2023 | 374.77% |
| Dec 31, 2022 | 10.31% |
| Sep 30, 2022 | 288.00% |
| Jun 30, 2022 | -78.17% |
| Mar 31, 2022 | -45.48% |
| Dec 31, 2021 | -70.11% |
| Sep 30, 2021 | 48.21% |
| Jun 30, 2021 | 44.29% |
| Mar 31, 2021 | 277.59% |
| Dec 31, 2020 | -56.61% |
| Sep 30, 2020 | 220.80% |
| Jun 30, 2020 | 23.76% |